Effect of anti CD45 on different immunosuppressive regimes in renal transplantation.
Talbot
D
D
Renal Transplant Unit, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Shenton
B K
BK
Bell
A
A
White
M
M
Glennon
A
A
Manas
D
D
Minford
E
E
Rix
D
D
Mathew
A
A
Kumar
A
A
Taylor
R M
RM
D000906:Antibodies / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D017493:Leukocyte Common Antigens / Q000276:immunology*; D007962:Leukocytes / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies
D000906:Antibodies; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D017493:Leukocyte Common Antigens; D001379:Azathioprine